Expression of ALC1 in tissues of esophageal squamous cell carcinoma and its effect on ESCC cell proliferation, invasion, and migration
10.3969/j.issn.1000-8179.2018.11.224
- VernacularTitle:ALC1蛋白在食管鳞癌中的表达及其对细胞增殖 侵袭 迁移的影响
- Author:
Fangfang LI
1
;
Lei MA
;
Zhen ZHANG
;
Yinghui ZHU
;
Xinyuan GUAN
;
Peng WANG
;
Yanru QIN
Author Information
1. 南阳市第一人民医院肿瘤科
- Keywords:
esophageal squamous cell carcinoma;
ALC1;
immunohistochemistry;
cell proliferation;
migration
- From:
Chinese Journal of Clinical Oncology
2018;45(11):572-576
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the expression of ALC1 protein during esophageal squamous cell carcinoma (ESCC) development and progression, so as to explore its association with clinicopathological characteristics and overall survival of ESCC patients, and the effect of ALC1 overexpression on malignant biological behavior of esophageal squamous cells. Methods: Immunohistochemistry (IHC) was used to detect ALC1 protein expression in 245 primary ESCC tissues and their paired normal esophageal mucous membranes, and to determine its correlation to gender, age, tumor cell differentiation, invasion, TNM stage, lymph nodes metastasis, and overall surviv-al rate of ESCC patients. MTT assay, colony formation assay, transwell invasion, and wound healing assay were used to observe the ef-fect of ALC1 on ESCC cell proliferation, invasion, and migration. Results: The expression ratio of ALC1 in esophageal squamous cell car-cinoma was higher compared with that in their paired normal esophageal mucous membranes (41.6% vs . 21.2% , P<0.05). Upregula-tion of ALC1 was associated with ESCC invasion, TNM stage, and lymph node metastasis (P<0.05). The overall survival of ESCC patients with ALC1 overexpression was significantly lower than that in patients with downregulated ALC1 expression (P=0.002). Therefore, ALC1 may promote the proliferation, invasion, and migration of ESCC cells. Conclusions: ALC1 upregulation may play an important role in the progression and development of ESCC. Upregulation of ALC1 leads to poorer disease prognosis, and could promote the prolifera-tion, invasion, and migration of the KYSE30 ESCC cells. Therefore, ALC1 may have potential prognostic value for ESCC patients.
